Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Endocrinology|August 1, 1993
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the ratL M Burrell, P A Phillips, J Stephenson, et al.
The American Journal of Medicine|December 26, 1989
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonistsC I Johnston, P G Hodsman, M Kohzuki, et al.
Journal of Travel Medicine|October 17, 1998
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancyP A Phillips-Howard, R Steffen, L Kerr, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the ratL M Burrell, R Chan, P A Phillips, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1995
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonismL M Burrell, P A Phillips, J Risvanis, et al.
The American Journal of Physiology|August 5, 1998
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the ratL M Burrell, P A Phillips, J Risvanis, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the ratL M Burrell, P A Phillips, J M Stephenson, et al.
Pageof 15